>Marché mondial du glaucome primaire à angle fermé, par type de maladie (glaucome aigu à angle fermé et glaucome chronique à angle fermé), type (diagnostic et traitement), utilisateur final (hôpitaux, cliniques spécialisées, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail et autres) - Tendances et prévisions de l'industrie jusqu'en 2031.
Analyse du marché et de la taille du glaucome primitif à angle fermé
Le marché mondial du glaucome primitif à angle fermé répond à l'incidence croissante du glaucome primitif à angle fermé dans le monde. Ce marché englobe les produits pharmaceutiques, les interventions chirurgicales et les outils de diagnostic visant à gérer et à traiter cette maladie menaçant la vue. Les innovations en matière de médicaments et de techniques chirurgicales au sein de ce marché contribuent à améliorer les résultats des patients, soulignant l'importance d'une détection et d'une intervention précoces pour prévenir la perte de vision associée au glaucome primitif à angle fermé.
Data Bridge Market Research analyse le marché mondial du glaucome primaire à angle fermé, qui était de 253,48 millions USD en 2023, et devrait atteindre 407,07 millions USD d'ici 2031, à un TCAC de 6,1 % au cours de la période de prévision 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.
Portée et segmentation du marché du glaucome primitif à angle fermé
|
Rapport métrique |
Détails |
|
Période de prévision |
2024-2031 |
|
Année de base |
2023 |
|
Années historiques |
2022 (personnalisable pour 2016-2021) |
|
Unités quantitatives |
Chiffre d'affaires en milliards USD, volumes en unités, prix en USD |
|
Segments couverts |
Type de maladie (glaucome aigu à angle fermé et glaucome chronique à angle fermé), type (diagnostic et traitement), utilisateur final (hôpitaux, cliniques spécialisées, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail et autres) |
|
Pays couverts |
États-Unis, Canada, Mexique, Allemagne, France, Italie, Royaume-Uni, Espagne, Russie, Autriche, Pays-Bas, Hongrie, Pologne, Suisse, Turquie, Norvège, Lituanie, Irlande, Reste de l'Europe, Japon, Chine, Inde, Australie, Singapour, Corée du Sud, Malaisie, Thaïlande, Indonésie, Philippines, Vietnam, Reste de l'Asie-Pacifique, Brésil, Argentine, Pérou, Reste de l'Amérique du Sud, Afrique du Sud, Égypte, Arabie saoudite, Israël, Émirats arabes unis, Koweït, Reste du Moyen-Orient et de l'Afrique |
|
Acteurs du marché couverts |
Johnson & Johnson Vision Care, Inc. (États-Unis), Aurolab (Inde), New World Medical, Inc. (États-Unis), Sight Sciences (États-Unis), NIDEK CO., LTD (Japon), BVI (États-Unis), MicroSurgical Technology (États-Unis), Bausch + Lomb (États-Unis), Oertli Instrumente AG (Suisse), Medisonic Equipments Pvt. Ltd. (Inde), Omni Lens Pvt. Ltd. (États-Unis), Appasamy Associates Private Limited (Inde), NOVAEYE MEDICAL (Australie), ZEISS Group (Allemagne), Alcon Inc. (Suisse), LIGHTMED (Taïwan), Reichert, Inc. (États-Unis), NewVision Softcom & Consultancy Pvt. Ltd |
|
Opportunités de marché |
|
Définition du marché
Le glaucome primitif à angle fermé est un type de glaucome caractérisé par le blocage progressif ou soudain de l'angle de drainage dans l'œil, ce qui entraîne une altération du drainage du liquide et une augmentation de la pression intraoculaire. Cette pression élevée peut endommager le nerf optique, entraînant une perte de vision. Les symptômes peuvent inclure une douleur oculaire intense, des maux de tête, une vision floue et des nausées. Un diagnostic et une intervention rapides sont essentiels pour prévenir une déficience visuelle irréversible, nécessitant souvent des interventions médicales ou chirurgicales pour soulager la pression intraoculaire et gérer la maladie.
Dynamique du marché mondial du glaucome primitif à angle fermé
Conducteurs
- Sensibilisation accrue de la population vieillissante
La population vieillissante est plus exposée au glaucome, notamment au glaucome primitif à angle fermé. Avec l’augmentation mondiale de l’espérance de vie, le nombre de personnes à risque est en augmentation. Cette évolution démographique crée une opportunité pour le marché de répondre à la demande croissante en matière de diagnostic, de surveillance et d’options de traitement du glaucome. Des campagnes de sensibilisation accrues sur la santé oculaire et des dépistages réguliers contribuent à une détection et un traitement précoces, offrant un terrain fertile pour la croissance du marché.
- L'incidence croissante du diabète et de l'hypertension augmente le risque de glaucome
Le diabète et l’hypertension sont des facteurs de risque connus du glaucome, notamment du glaucome primitif à angle fermé. Avec l’augmentation mondiale de la prévalence du diabète et de l’hypertension, on observe une augmentation correspondante du nombre de personnes à risque de développer un glaucome. Ce nombre croissant de patients contribue à l’expansion du marché du glaucome primitif à angle fermé, car les prestataires de soins de santé se concentrent sur la satisfaction des besoins de santé oculaire de cette population.
Opportunités
- L'expansion du marché renforce la sensibilisation de la population
Les opportunités résident dans l'expansion du marché à l'échelle mondiale, en particulier dans les régions où le taux de prévalence du glaucome primitif à angle fermé est élevé. Les entreprises qui se concentrent sur l'établissement d'une forte présence sur les marchés émergents et collaborent avec les prestataires de soins de santé pour améliorer la sensibilisation et l'accessibilité offrent un potentiel de croissance substantielle du marché et d'amélioration des résultats pour les patients en répondant aux besoins non satisfaits dans ces régions.
- Médecine personnalisée pour thérapies ciblées
La tendance vers la médecine personnalisée représente une opportunité pour le marché du glaucome primaire à angle fermé. L’adaptation des approches thérapeutiques en fonction des caractéristiques individuelles des patients, des facteurs génétiques et de la progression de la maladie peut améliorer l’efficacité des interventions. Les entreprises qui investissent dans la recherche pour développer des thérapies ciblées et des solutions de médecine de précision pour le glaucome primaire à angle fermé peuvent acquérir un avantage concurrentiel en fournissant des soins plus efficaces et personnalisés, favorisant ainsi les avancées dans le domaine.
Contraintes/Défis
- Les consommateurs confrontés à des défis en matière d'accessibilité
L'accessibilité aux outils de diagnostic et aux options de traitement avancés, associée aux contraintes financières dans certaines régions, peut constituer un frein important au marché du glaucome à angle fermé primaire. Les patients de certaines régions peuvent avoir du mal à accéder à des services de soins oculaires spécialisés ou à se payer des médicaments coûteux contre le glaucome ou des interventions chirurgicales, ce qui limite le potentiel de croissance du marché dans ces régions.
- Tolérance des médicaments chez les consommateurs
Le marché mondial du glaucome primaire à angle fermé est associé aux effets indésirables potentiels et aux problèmes de tolérance liés aux médicaments couramment prescrits pour gérer la pression intraoculaire. Certains patients peuvent ressentir des effets secondaires qui affectent leur qualité de vie ou nécessitent des changements dans les plans de traitement. Ces problèmes de tolérance aux médicaments peuvent entraîner une non-observance et un arrêt du traitement, ce qui affecte l'efficacité globale des stratégies de traitement et peut entraver la croissance du marché.
Ce rapport sur le marché mondial du glaucome à angle fermé primaire fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et local, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché mondial du glaucome à angle fermé primaire, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché.
Développements récents
- Le 21 décembre, Aerie Pharmaceuticals a collaboré avec Santen Pharmaceuticals, annoncé en décembre 2021, pour se concentrer sur le développement et la commercialisation de produits de traitement du glaucome, notamment Rhopressa/Rhokiinsa et Rocklatan/Roclanda. Cette collaboration vise à renforcer la présence commerciale des deux sociétés dans des régions telles que l'Inde, l'Europe, l'Océanie, la Chine et certaines parties de l'Amérique latine, favorisant ainsi une expansion mondiale de leurs offres de traitement du glaucome
- In March 2021, Teva Pharmaceuticals bolstered its product portfolio by introducing the first generic version of AZOPT (brinzolamide ophthalmic suspension) 1 percent in the U.S. This move enhances Teva's capabilities in addressing open-angle glaucoma and ocular hypertension, contributing to its position in the pharmaceutical market for ocular conditions
- In June 2020, Johnson & Johnson Vision Care, Inc. demonstrated its commitment to supporting eye care during the COVID-19 pandemic by announcing a generous donation of USD 0.30 million. The funds were allocated to Optometry Cares – The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation. This donation aimed to assist practitioners in their efforts to provide essential eye care services to communities affected by the pandemic, underscoring the company's dedication to promoting eye health during challenging times
Global Primary Angle-Closure Glaucoma Market Scope
The global primary angle-closure glaucoma market is segmented on the basis of the disease type, type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Disease Type
- Acute Angle-Closure Glaucoma
- Chronic Angle-Closure Glaucoma
Type
- Diagnosis
- Treatment
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Global Primary Angle-Closure Glaucoma Market Regional Analysis/Insights
The global primary angle-closure glaucoma market is analysed and market size information is provided by the country, disease type, type, end user and distribution channel as referenced above.
The countries covered in the global primary angle-closure glaucoma market report are the U.S., Canada, Mexico, Germany, France, Italy U.K., Spain, Russia, Austria, Netherlands, Hungary, Poland, Switzerland, Turkey, Norway, Lithuania, Ireland, rest of Europe, Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Egypt, Saudi Arabia, Israel, U.A.E., Kuwait and rest of Middle East and Africa.
North America is expected to dominate the primary angle-closure glaucoma market, primarily attributed to its status as the largest consumer market with a robust GDP. The U.S., boasting the highest household spending globally, emerges as a key player. The region exhibits elevated rates in both the diagnosis and treatment segments, solidifying its position as the primary market for products related to primary angle-closure glaucoma.
L’Europe devrait connaître le TCAC le plus élevé au cours de la période de prévision, grâce aux vastes initiatives de recherche en cours en Allemagne. La région bénéficie d’infrastructures de soins de santé avancées, en particulier dans le domaine du diagnostic, ce qui renforce son potentiel de croissance. Avec une base solide pour les études médicales et des installations de soins de santé de qualité supérieure, l’Europe se positionne comme un pôle clé pour les avancées dans le secteur des soins de santé, contribuant à la croissance prévue dans les années à venir.
La région Asie-Pacifique devrait connaître une croissance significative, tirée par l'évolution des modes de vie et l'urbanisation croissante. Le Japon, leader mondial, devrait dominer le marché dans la région en raison d'une augmentation substantielle de l'utilisation des produits et des taux de diagnostic, en particulier dans le contexte du glaucome primitif à angle fermé. L'augmentation rapide de la sensibilisation à cette maladie contribue à la prédominance du Japon sur le marché, le positionnant comme un acteur clé dans le paysage en évolution des soins oculaires en Asie-Pacifique.
La région du Moyen-Orient et de l’Afrique devrait connaître une croissance significative entre 2024 et 2031, tirée par une augmentation substantielle de la sensibilisation à la maladie ciblée dans ces pays. La croissance prévue est attribuée à la prise de conscience et à la compréhension croissantes de cette maladie particulière dans la région. Cette prise de conscience accrue est susceptible de contribuer à une demande accrue de solutions de soins de santé, conduisant à l’expansion prévue des secteurs pharmaceutique et de la santé au Moyen-Orient et en Afrique.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies
Le marché mondial du glaucome à angle fermé primaire vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché mondial du glaucome à angle fermé primaire, l'impact de la technologie utilisant les courbes de ligne de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché mondial du glaucome à angle fermé primaire. Les données sont disponibles pour la période historique 2016-2021.
Analyse du paysage concurrentiel et des parts de marché mondiales du glaucome à angle fermé primaire
Le paysage concurrentiel du marché mondial du glaucome à angle fermé primaire fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais cliniques, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial du glaucome à angle fermé primaire.
Certains des principaux acteurs opérant sur le marché mondial du glaucome primaire à angle fermé sont :
- Johnson & Johnson Vision Care, Inc. (États-Unis)
- Aurolab (Inde)
- New World Medical, Inc. (États-Unis)
- Sciences de la vue (États-Unis)
- NIDEK CO., LTD (Japon)
- Îles Vierges britanniques (États-Unis)
- Technologie microchirurgicale (États-Unis)
- Bausch + Lomb (États-Unis)
- Oertli Instrumente AG (Suisse)
- Medisonic Equipments Pvt. Ltd. (Inde)
- Omni Lens Pvt. Ltd. (États-Unis)
- Appasamy Associates Private Limited (Inde)
- NOVAEYE MEDICAL (Australie)
- Groupe ZEISS (Allemagne)
- Alcon Inc. (Suisse)
- LIGHTMED (Taïwan)
- Reichert, Inc. (États-Unis)
- NewVision Softcom & Consultancy Pvt. Ltd (Inde)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end user coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- Regulatory Framework
- Pipeline analysis
- market overview
- drivers
- INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA
- INCREASING WOMEN POPULATION
- RISE IN GERIATRIC POPULATION
- ADVANCEMENTS IN SURGICAL TREATMENT OF THE DISEASE
- INCREASED ECONOMIC BURDEN
- RESTRAINTS
- HIGH SURGICAL COSTS OF PACG
- INADEQUATE REIMBURSEMENT SCENARIO
- DELAYED AND MISDIAGNOSIS OF PACG
- OPPORTUNITIES
- INCREASING GOVERNMENT INITIATIVES TOWARDS GLAUCOMA
- RECENT APPROVAL BY GOVERNING BODIES
- INCREASING INCIDENCES IN EMERGING MARKET
- RAPID TRANSITION FROM PACG MEDICATION TO SURGERIES
- CHALLENGES
- RISKS ASSOCIATED WITH SURGICAL PROCEDURES
- LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
- LIMITED ACCESS TO TREATMENT
- IMPACT OF COVID-19 ON GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS
- CONCLUSION
- global PRIMARY ANGLE CLOSURE GLAUCOMA Market, By DISEASE TYPE
- overview
- acute angle-closure glaucoma market
- chronic angle-closure glaucoma market
- GLOBAL primary angle-closure glaucoma MARKET, BY TYPE
- overview
- Diagnosis
- primary test
- GONIOSCOPY EXAMINATION
- SLIT-LAMP EXAMINATION
- AUTOMATIC STATIC PERIMETRY
- SECONDARY test
- ULTRASOUND BIOMICROSCOPY
- ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY (OCT)
- RETINAL OCT
- FUNDOSCOPY
- OTHERS
- Treatment
- Surgical Iridectomy
- TRABECULECTOMY
- Micro invasive glaucoma technique (MIGS)
- goniotomy
- Others
- GLOBAL primary angle-closure glaucoma MARKET, BY end user
- overview
- HoSpitals
- AMbulatory surgical Centers
- Specialty Clinics
- others
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY distribution channel
- overview
- direct tender
- retail sales
- Others
- GLOBAL primary angle-closure glaucoma MARKET, BY GEOGRAPHY
- OVERVIEW
- NORTH AMERICA
- U.S.
- CANADA
- MEXICO
- EUROPE
- GERMANY
- FRANCE
- ITALY
- U.K.
- SPAIN
- RUSSIA
- AUSTRIA
- NETHERLANDS
- HUNGARY
- POLAND
- SWITZERLAND
- TURKEY
- NORWAY
- LITHUANIA
- IRELAND
- REST OF EUROPE
- ASIA-PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SINGAPORE
- SOUTH KOREA
- MALAYSIA
- THAILAND
- INDONESIA
- PHILIPPINES
- VIETNAM
- REST OF ASIA-PACIFIC
- SOuth america
- BRAZIL
- ARGENTINA
- PERU
- REST OF SOUTH AMERICA
- middle east and Africa
- SOUTH AFRICA
- EGYPT
- SAUDI ARABIA
- ISRAEL
- UAE
- KUWAIT
- REST OF MIDDLE EAST AND AFRICA
- Global primary angle-closure glaucoma Market: COMPANY landscape
- company share analysis: global
- company share analysis: north america
- company share analysis: europe
- company share analysis: Asia-Pacific
- SWOT
- company profiles
- johnson & johnson vision care, inc. (a subsidiary of johnson & johnson services, inc.)
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- bausch & lomb incorporated (a subsidiary of bausch health Companies Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- alcon inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zeiss International
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NOVA EYE MEDICAL LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NIDEK CO., LTD
- COMPANY SNAPShot
- product Portfolio
- RECENT DEVELOPMENTS
- allergan (a subsidiary of abbvie inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- APPASAMY ASSOCIATES
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- aurolab
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- BVI
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- LIGHTMED
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Luneau technology usa
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- medisonic equipments pvt. ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- microsurgical technology
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- new vision
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- New World Medical, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Oertli Instrumente AG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- omni lens
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Reichert, inc. (A business unit of ametek.inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Sight Sciences, inc.
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Liste des tableaux
TABLE 1 Global Primary Angle-Closure Glaucoma Market, Pipeline Analysis
TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS
TABLE 3 global Primary angle closure glaucoma market, By disease type, 2019-2028 (USD million)
TABLE 4 Global Acute-angle closure glaucoma in Primary angle closure glaucoma Market, By Region, 2019-2028 (USD Million)
TABLE 5 Global chronic angle-closure glaucoma in Primary angle closure glaucoma Market,By Region, 2019-2028 (USD Million)
TABLE 6 Global Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 7 Global Diagnosis in Primary Angle-Closure Glaucoma Market, By region, 2019-2028 (USD Million)
TABLE 8 Global Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 9 Global Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 10 Global Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 11 Global Treatment in Primary Angle-Closure Glaucoma Market, By Disease Type 2019-2028 (USD Million)
TABLE 12 Global Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 13 Global Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 14 Global Hospitals in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 15 Global Ambulatory Surgical Centers in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 16 Global Specialty Clinics in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 17 Global Others in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 18 Global Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 19 Global Direct Tender in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 20 Global Retail Sales in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 21 Global Others in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 22 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 24 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 25 North America Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 26 North America Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 27 North America Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 28 North America Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 29 North America Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 30 North America Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 31 North America Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 32 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 33 U.S. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 34 U.S. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 35 U.S. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 36 U.S. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 37 U.S. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 38 U.S. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 39 U.S. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 40 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 41 CANADA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 42 CANADA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 43 CANADA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 44 CANADA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 45 CANADA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 46 CANADA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 47 CANADA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 48 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 49 MEXICO Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 50 MEXICO Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 51 MEXICO Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 52 MEXICO Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 53 MEXICO Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 54 MEXICO Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 55 MEXICO Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 56 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 57 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 58 EUROPE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 59 EUROPE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 60 EUROPE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 61 EUROPE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 62 EUROPE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 63 EUROPE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 64 EUROPE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 65 Germany PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 66 GERMANY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 67 GERMANY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 68 GERMANY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 69 GERMANY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 70 GERMANY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 71 GERMANY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 72 GERMANY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 73 FRANCE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 74 FRANCE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 75 FRANCE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 76 FRANCE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 77 FRANCE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 78 FRANCE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 79 FRANCE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 80 FRANCE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 81 ITALY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 82 ITALY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 83 ITALY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 84 ITALY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 85 ITALY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 86 ITALY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 87 ITALY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 88 ITALY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 89 U.K. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 90 U.K. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 91 U.K. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 92 U.K. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 93 U.K. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 94 U.K. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 95 U.K. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 96 U.K. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 97 SPAIN PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 98 SPAIN Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 99 SPAIN Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 100 SPAIN Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 101 SPAIN Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 102 SPAIN Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 103 SPAIN Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 104 SPAIN Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 105 RUSSIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 106 RUSSIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 107 RUSSIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 108 RUSSIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 109 RUSSIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 110 RUSSIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 111 RUSSIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 112 RUSSIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 113 AUSTRIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 114 AUSTRIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 115 AUSTRIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 116 AUSTRIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 117 AUSTRIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 118 AUSTRIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 119 AUSTRIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 120 AUSTRIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 121 NETHERLANDS PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 122 NETHERLANDS Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 123 NETHERLANDS Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 124 NETHERLANDS Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 125 NETHERLANDS Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 126 NETHERLANDS Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 127 NETHERLANDS Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 128 NETHERLANDS Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 129 HUNGARY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 130 HUNGARY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 131 HUNGARY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 132 HUNGARY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 133 HUNGARY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 134 HUNGARY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 135 HUNGARY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 136 HUNGARY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 137 POLAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 138 POLAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 139 POLAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 140 POLAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 141 POLAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 142 POLAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 143 POLAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 144 POLAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 145 SWITZERLAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 146 SWITZERLAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 147 SWITZERLAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 148 SWITZERLAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 149 SWITZERLAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 150 SWITZERLAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 151 SWITZERLAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 152 SWITZERLAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 153 TURKEY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 154 TURKEY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 155 TURKEY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 156 TURKEY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 157 TURKEY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 158 TURKEY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 159 TURKEY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 160 TURKEY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 161 NORWAY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 162 NORWAY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 163 NORWAY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 164 NORWAY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 165 NORWAY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 166 NORWAY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 167 NORWAY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 168 NORWAY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 169 LITHUANIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 170 LITHUANIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 171 LITHUANIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 172 LITHUANIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 173 LITHUANIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 174 LITHUANIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 175 LITHUANIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 176 LITHUANIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 177 IRELAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 178 IRELAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 179 IRELAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 180 IRELAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 181 IRELAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 182 IRELAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 183 IRELAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 184 IRELAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 185 REst of europe Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
TABLE 186 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 187 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 188 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 189 ASIA-PACIFIC Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 190 ASIA-PACIFIC Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 191 ASIA-PACIFIC Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 192 ASIA-PACIFIC Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 193 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 194 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 195 JAPAN PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 196 JAPAN Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 197 JAPAN Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 198 JAPAN Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 199 JAPAN Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 200 JAPAN Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 201 JAPAN Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 202 JAPAN Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 203 CHINA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 204 CHINA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 205 CHINA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 206 CHINA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 207 CHINA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 208 CHINA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 209 CHINA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 210 CHINA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 211 INDIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 212 INDIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 213 INDIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 214 INDIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 215 INDIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 216 INDIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 217 INDIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 218 INDIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 219 AUSTRALIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 220 AUSTRALIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 221 AUSTRALIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 222 AUSTRALIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 223 AUSTRALIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 224 AUSTRALIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 225 AUSTRALIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 226 AUSTRALIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 227 SINGAPORE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 228 SINGAPORE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 229 SINGAPORE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 230 SINGAPORE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 231 SINGAPORE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 232 SINGAPORE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 233 SINGAPORE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 234 SINGAPORE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 235 SOUTH KOREA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 236 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 237 SOUTH KOREA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 238 SOUTH KOREA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 239 SOUTH KOREA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 240 SOUTH KOREA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 241 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 242 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 243 MALAYSIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 244 MALAYSIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 245 MALAYSIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 246 MALAYSIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 247 MALAYSIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 248 MALAYSIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 249 MALAYSIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 250 MALAYSIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 251 THAILAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 252 THAILAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 253 THAILAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 254 THAILAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 255 THAILAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 256 THAILAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 257 THAILAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 258 THAILAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 259 INDONESIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 260 INDONESIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 261 INDONESIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 262 INDONESIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 263 INDONESIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 264 INDONESIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 265 INDONESIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 266 INDONESIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 267 PHILIPPINES PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 268 PHILIPPINES Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 269 PHILIPPINES Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 270 PHILIPPINES Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 271 PHILIPPINES Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 272 PHILIPPINES Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 273 PHILIPPINES Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 274 PHILIPPINES Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 275 VIETNAM PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 276 VIETNAM Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 277 VIETNAM Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 278 VIETNAM Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 279 VIETNAM Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 280 VIETNAM Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 281 VIETNAM Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 282 VIETNAM Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 283 REst of ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
TABLE 284 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 285 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 286 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 287 SOUTH AMERICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 288 SOUTH AMERICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 289 SOUTH AMERICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 290 SOUTH AMERICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 291 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 292 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 293 BRAZIL PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 294 BRAZIL Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 295 BRAZIL Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 296 BRAZIL Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 297 BRAZIL Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 298 BRAZIL Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 299 BRAZIL Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 300 BRAZIL Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 301 ARGENTINA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 302 ARGENTINA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 303 ARGENTINA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 304 ARGENTINA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 305 ARGENTINA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 306 ARGENTINA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 307 ARGENTINA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 308 ARGENTINA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 309 PERU PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 310 PERU Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 311 PERU Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 312 PERU Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 313 PERU Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 314 PERU Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 315 PERU Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 316 PERU Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 317 REst of SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
TABLE 318 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 319 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 320 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 321 MIDDLE EAST AND AFRICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 322 MIDDLE EAST AND AFRICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 323 MIDDLE EAST AND AFRICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 324 MIDDLE EAST AND AFRICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 325 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 326 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 327 SOUTH AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 328 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 329 SOUTH AFRICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 330 SOUTH AFRICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 331 SOUTH AFRICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 332 SOUTH AFRICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 333 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 334 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 335 EGYPT PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 336 EGYPT Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 337 EGYPT Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 338 EGYPT Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 339 EGYPT Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 340 EGYPT Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 341 EGYPT Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 342 EGYPT Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 343 SAUDI ARABIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 344 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 345 SAUDI ARABIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 346 SAUDI ARABIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 347 SAUDI ARABIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 348 SAUDI ARABIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 349 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 350 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 351 ISRAEL PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 352 ISRAEL Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 353 ISRAEL Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 354 ISRAEL Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 355 ISRAEL Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 356 ISRAEL Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 357 ISRAEL Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 358 ISRAEL Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 359 UAE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 360 UAE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 361 UAE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 362 UAE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 363 UAE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 364 UAE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 365 UAE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 366 UAE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 367 KUWAIT PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 368 KUWAIT Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 369 KUWAIT Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 370 KUWAIT Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 371 KUWAIT Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 372 KUWAIT Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 373 KUWAIT Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 374 KUWAIT Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 375 REst of MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
Liste des figures
FIGURE 1 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: segmentation
FIGURE 2 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET : data triangulation
FIGURE 3 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 Global primary angle-closure glaucoma market: MARKET end user coverage GRID
FIGURE 10 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Global primary angle-closure glaucoma market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in global primary angle-closure glaucoma market IN the forecast period of 2021 to 2028
FIGURE 13 INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA and ADVANCEMENT IN SURGICAL TREATMENT OF THE DISEASE are DRIVing THE global primary angle-closure glaucoma market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 14 ACUTE ANGLE-CLOSURE GLAUCOMA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET IN 2021 & 2028
FIGURE 15 asia-PACIFIC is the fastest growing market in global primary angle-closure glaucoma market in the forecast period of 2021 to 2028
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
FIGURE 17 global Primary angle closure glaucoma market: By disease type, 2020
FIGURE 18 global Primary angle closure glaucoma market: By disease type, 2020-2028 (USD Million)
FIGURE 19 global Primary angle closure glaucoma market: By disease type, CAGR (2020-2028)
FIGURE 20 global Primary angle closure glaucoma market: By disease type, LIFELINE CURVE
FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, 2020
FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE 2020-2028 (USD Million)
FIGURE 23 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, CAGR (2021-2028)
FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, LIFELINE CURVE
FIGURE 25 global Primary Angle-Closure Glaucoma market: BY end users, 2020
FIGURE 26 global Primary Angle-Closure Glaucoma market: BY end users, 2020-2028 (USD Million)
FIGURE 27 global Primary Angle-Closure Glaucoma market: BY end users, CAGR (2021-2028)
FIGURE 28 global Primary Angle-Closure Glaucoma market: BY end users, LIFELINE CURVE
FIGURE 29 global Primary Angle-Closure Glaucoma market: BY distribution channel, 2020
FIGURE 30 global Primary Angle-Closure Glaucoma market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 31 global Primary Angle-Closure Glaucoma market: BY distribution channel, CAGR (2021-2028)
FIGURE 32 global Primary Angle-Closure Glaucoma market: BY distribution, LIFELINE CURVE
FIGURE 33 GLobal PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 34 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 35 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 36 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2020-2028)
FIGURE 38 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 39 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 40 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 43 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 44 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 45 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 48 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 49 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 50 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 51 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 52 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 53 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 54 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 55 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 56 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 57 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 58 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 59 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 60 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 61 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 62 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 63 Global primary angle-closure glaucoma market: company share 2020 (%)
FIGURE 64 north america primary angle-closure glaucoma market: company share 2020 (%)
FIGURE 65 europe primary angle-closure glaucoma market: company share 2020 (%)
FIGURE 66 Asia-Pacific primary angle-closure glaucoma market: company share 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
